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lesion associated with unstable angina or acute myocardial infarc-
tion has specific anatomic characteristics that can be elucidated
only by quantitativecoronary angiography. These include luminal
cross-sectional area < I mrrr' and a high degree of irregularity of
the lesion (6,7). This observation has been supported by recent
studies with angioscopy in patients with unstable angina (8) and
detailed pathologic studies (9).
Second, lesions likely to reocclude early after thrombolytic
therapy for acute myocardial infarction have a specific character-
istic that is best elucidated by quantitative coronary angiography
(that is, lesion cross-sectional area <0.35 mrrr') (10).
Third, lesions with severely decreased flow reserve have a
cross-sectional area < I to 2 rnrrr' and are likely to be associated
with clear-cut reversibleperfusiondefects on thallium scintigrams
(II). Other studies indicate that patients with reversible perfusion
defects on thallium scintigrams have a 12-fold increase in the
frequency of coronary events versus those patients with negative
scans (12) irrespective of angiographic findings.
Althoughlong-termfollow-up studies relativeto the prognostic
value of quantitative coronary angiography and the direct mea-
surement of coronary flow reserve in individual coronary lesions
are unavailable, to doubt the value of these new approaches is an
ultraconservative view.
The visual analysis of the coronary angiogram has major flaws
that it is hopedwill be helpedbyquantitativecoronaryangiography
and direct assessment of flow reserve. Work in this area should
be strongly supported. Althoughsubjectiveevaluationof coronary
angiograms may correlate with prognosis in large groups of pa-
tients, it is likely that sophisticated analysis may provide an ap-
proach to accurate predictionof prognosis in an individual patient.
This is greatly needed in clinical practice.
MELVIN L. MARCUS, MD, FACC
PETER T. KIRCHNER, MD
University Of Iowa
Iowa City, Iowa 52242
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Conduction System in Sudden Death
In their article on sudden death in young adults (I), Bharati and
Lev stress that a complete examination of the heart's conduction
system is rarely done, Having long been personally engaged in
this very type of examination, I invite the authors, as well as their
readers, to consult recent data available in the American literature
(2-5). They will realize, for instance, that the "mild Ebstein
malformation," pointed out and illustrated in Case 3, is just what
I described (for the first time) a couple of years ago (3,5) in the
setting of sudden cardiac death.
My Latin ancestors said it: "unicuique suum"!
LlNO ROSSI, MD
Via Annunciata 23/4
20121 Milan, Italy
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Reply
I want to thank Rossi for bringing to our attention his excellent
work on suddendeath. In our paper we made no attempt to review
the work that has been done in this field, which we still believe
is scant. Sudden unexpected death in young people is not a rare
occurrence,Despitethis, the conductionsystemis notoften studied
in this entity. We look forward to seeing more work by Rossi and
his colleagues on sudden unexpected death in young people.
Sic transit gloria mundi!
SAROJA BHARATI, MD
Department of Pathology
Deborah Heart and Lung Center
Browns Mills, New Jersey 08015
Percutaneous Balloon Dilation of
Rheumatic Mitral Stenosis by the
Transarterial Approach
Mitral valvuloplasty has been used as an alternative to surgical
mitralcommissurotomy and the results published by McKayet al.
(I) are very encouraging. In addition to the editorial comments
by Beekman (2), a new technical aspect should be reported. Since
September 1986 we have performedballoon valvuloplasty in nine
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patients (mean age 29 :±: 9 years) with rheumatic mitral stenosis
through the transarterial approach in a manner different from that
used by Babic et al. (3). Percutaneously through the right femoral
artery I) an 8F Sones catheter was introduced into the left atrium;
2) through the Sones catheter a long guide wire also was introduced
into the left atrium; 3) the Sones catheter was removed and the
long guide wire was maintained in the left atrium; 4) through this
long guide wire a balloon catheter was placed within the mitral
valve and inflated several times for about 10 to 15 s each. We
used only one balloon per procedure (diameter range 15 to 25
mm). In the last case, two long guide wires were introduced into
the left atrium but the second balloon could not loop through the
apex of the left ventricle to reach the mitral valve. Mean pulmonary
artery pressure decreased from 35.8 :±: II to 24 :±: 9 mm Hg and
the mitral valve gradient from 19 :±: 8.5 to 9.5 :±: 4.7 mm Hg.
At the same session we performed in one patient a tricuspid val-
vuloplasty and in another patient we performed tricuspid and aortic
valvuloplasty. Although a potential complication in this approach,
improper positioning of the balloon catheter through the mitral
tendineae chordae was not observed in these nine cases. No sig-
nificant mitral regurgitation was observed after the procedure.
One advantage of the transarterial approach is that it avoids
transseptal punctures and a possible residual atrial septal defect.
It seems to us that the transarterial approach is an alternative to
mitral valvuloplasty, but it will be important to demonstrate the
feasibility of the double balloon technique as already demonstrated
in the transseptal approach (l ,4).
JORGE ROBERTO BUCHLER, MD, FACC
Institute "Dante Pazzanese" of Cardiology
Caixa Postal 215
Sao Paulo, Brazil
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Reply
Buchler and associates are to be complimented on their success in
using an alternative transarterial approach to balloon mitral val-
vuloplasty. Their work supplements the previous reports from Ba-
bic et al. on a retrograde approach to dilate the mitral valve. In
selected patients in whom surgical intervention is deferred and in
whom a retrograde transseptal approach to balloon valvuloplasty
is impossible, this technique may serve as a useful alternative.
Several major limitations of a retrograde transarterial approach
to the mitral valve need to be discussed, however. The first, as
noted by Buchler, concerns crossing the mitral valve retrograde
with a guide wire. In particular, improper positioning of this guide
wire through the mitral chordae could subsequently lead to im-
proper positioning of a mitral valvuloplasty balloon that could
result in chordal rupture and massive mitral regurgitation. The
anterograde technique described in our study attempts to avoid this
problem by crossing the mitral valve from the left atrial side with
a balloon-tipped catheter. Crossing the valve in this manner with
an inflated balloon minimizes the chance that subsequent guide
wire placement will be between mitral chordae.
A second technical factor that needs to be addressed concerns
the percutaneous arterial insertion of large valvuloplasty balloons,
ranging from 15 to 25 mm in outer diameter. At present, the use
of these balloons requires insertion of arterial sheaths 2: 12F in
size. As a result, there may be a significant incidence of damage
to the femoral artery, particularly in elderly patients in whom
valvuloplasty may be chosen as a nonsurgical alternative. A final
technical factor that needs to be mentioned concerning the trans-
arterial approach involves the stability of guide wire placement
during the performance of mitral valvuloplasty. In particular, mo-
tion of the balloon during inflation through the mitral anulus may
result in loss of guide wire positioning across the mitral valve from
the left ventricle to the left atrium. Because repositioning of the
guide wire through the mitral valve by a retrograde approach may
be time consuming, this may be a major technical limitation of
the described procedure.
Major limitations of the transseptal anterograde approach to
mitral valvuloplasty that are improved on with a transarterial ap-
proach are also mentioned by Buchler. In particular, the transar-
terial approach avoids transseptal puncture and a possible residual
atrial septal defect. There is no question that the transseptal ret-
rograde approach should be performed only by physicians who are
already skilled in performing transseptal catheterization. Without
this training, attempted mitral valvuloplasty will most certainly
result in a large incidence of myocardial perforation. With respect
to creation of an atrial septal defect, it is my feeling that this
complication is purely a result of the large diameter valvuloplasty
balloons used in the technique. Improvements in catheter designs
with decreases in deflated balloon profiles of valvuloplasty cath-
eters will, it is hoped, eliminate the incidence of atrial septal defects
in future valvuloplasty studies.
RAYMOND G. McKAY, MD
Cardiac Catheterization Laboratory
Beth Israel Hospital
Harvard Medical School
Boston, Massachusetts 02215
